← All peptides
Collagen & Skin
Research Chemical

Hexapeptide-9

Also known as: Collaxyl

Hexapeptide-9 is a synthetic collagen-sequence peptide used in anti-aging skincare. It is a cosmetic ingredient, not an FDA-approved drug.

Last updated

Mechanism of Action

Hexapeptide-9 repeats a short sequence found in collagen and is classed as a matrikine, a fragment intended to signal dermal fibroblasts to make more extracellular matrix such as collagen. Like most peptides it penetrates intact skin poorly, and recent work has focused on delivery enhancers and on a cyclized variant designed to be more stable. Most mechanistic data come from supplier or laboratory studies rather than independent human trials of the plain peptide.

Half-life
Not well established
Administration Routes
Topical
Research Status
Research Chemical

Reported Benefits

  • Marketed to support collagen production
  • Marketed to reduce the look of fine lines
  • Laboratory and enhancer-formulation data only
  • Independent trials of the plain peptide are lacking

Potential Side Effects

  • Mild redness or irritation
  • Contact sensitivity to the formulation
  • Long-term topical safety data are limited

Common Dosing

There is no medical dose: hexapeptide-9 is a cosmetic ingredient used at low concentrations in finished serums and creams, and the formulation is set by the product manufacturer. Follow the product label.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Known sensitivity to the product or its ingredients
  • Broken, infected or inflamed skin

No documented stacking partners for Hexapeptide-9 yet.

  • Pioneering ionic liquids in neuro-soothing: Enhanced transdermal delivery of collagen peptides and their synergistic anti-aging functions

    2025

    Note: Tests hexapeptide-9 delivered with an ionic-liquid enhancer; co-authored by an ingredient manufacturer.

    View

No. As of 2026 it is a cosmetic ingredient, and US cosmetics do not need FDA premarket approval; it is not an approved drug for any condition.

Limited. Published work is mostly laboratory or formulation research, often by ingredient makers, and a 2025 positive skin trial tested a cyclized variant rather than standard hexapeptide-9.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.